KMID : 0363220220600020135
|
|
Korean Journal of Dermatology 2022 Volume.60 No. 2 p.135 ~ p.138
|
|
A Case of Nummular Eczema-Like Eruption after Secukinumab Treatment
|
|
Eun Dae-Hwi
Kim Dong-Min Lee Ji-Su Yoon Tae-Young Lee Ji-Yeoun
|
|
Abstract
|
|
|
Secukinumab is an anti-interleukin 17A monoclonal antibody used for treating chronic plaque psoriasis. Eczematous eruption is a relatively unknown adverse effect of secukinumab. A 32-year-old man developed eczematous eruptions on both lower extremities following secukinumab treatment for severe plaque psoriasis. The lesions were clinically diagnosed as a nummular eczema-like eruption and were treated with topical corticosteroids without switching or stopping secukinumab. Considering the increased use of secukinumab and other interleukin-17A inhibitors, dermatologists should be aware of the cutaneous side effects of the drug.
|
|
KEYWORD
|
|
Eczema, Interleukin-17A, Psoriasis
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|